TOXICITY OF LEVAMISOLE AND 5-FLUOROURACIL IN HUMAN-COLON CARCINOMA-CELLS

被引:52
作者
GREM, JL
ALLEGRA, CJ
机构
关键词
D O I
10.1093/jnci/81.18.1413
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1413 / 1417
页数:5
相关论文
共 31 条
[1]  
Amery W K, 1984, IMMUNE MODULATION AG, P383
[2]   INHIBITION OF INTERFERON OR SOLUBLE IMMUNE-RESPONSE SUPPRESSOR (SIRS) MEDIATED SUPPRESSION BY LEVAMISOLE [J].
AUNE, TM ;
PIERCE, CW .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1983, 5 (01) :91-98
[3]   ADJUVANT CHEMOTHERAPY AND IMMUNOTHERAPY FOR COLORECTAL-CANCER - PRELIMINARY COMMUNICATION [J].
BANCEWICZ, J ;
CALMAN, KC ;
MACPHERSON, SG ;
MCARDLE, CS ;
MCVIE, JG ;
SOUKOP, M .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1980, 73 (03) :197-199
[4]  
BEDIKIAN AY, 1978, ANCER, V42, P169
[5]  
BORDEN EC, 1982, IMMUNOTHERAPY HUMAN, P231
[6]  
BRATTAIN MG, 1981, CANCER RES, V41, P1751
[7]   A CONTROLLED EVALUATION OF RECENT APPROACHES TO BIOCHEMICAL MODULATION OR ENHANCEMENT OF 5-FLUOROURACIL THERAPY IN COLORECTAL-CARCINOMA [J].
BUROKER, TR ;
MOERTEL, G ;
FLEMING, TR ;
EVERSON, LK ;
CULLINAN, SA ;
KROOK, JE ;
MAILLIARD, JA ;
MARSCHKE, RF ;
KLAASSEN, DJ ;
LAURIE, JA ;
MOON, MD .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) :1624-1631
[8]  
DUJARDIN P, 1976, THERAPIE, V31, P733
[9]   RESISTANCE OF CCRF-CEM CLONED SUBLINES TO 5-FLUORODEOXYURIDINE ASSOCIATED WITH ENHANCED PHOSPHATASE-ACTIVITIES [J].
FERNANDES, DJ ;
CRANFORD, SK .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (01) :125-132
[10]  
GARIBDZHANIAN BT, 1977, ANTITUMOR DRUG THER, V3, P74